The industry needs to embrace innovation with technology towards novel drug development to remain relevant in the marketplace.
The industry needs to embrace innovation with technology towards novel drug development to remain relevant in the marketplace.
A Chinese startup is shaking the U.S. supremacy in generative artificial intelligence. Are we heading towards a collapse of barriers to entry accelerating the deployment of this technology? Could Europe offer a third way to the future?